Medifast, Inc.
MED
$12.72
-$0.40-3.05%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -110.33% | -97.90% | -93.89% | -77.93% | -52.20% |
| Total Depreciation and Amortization | -4.99% | -3.05% | -71.00% | 7.80% | 16.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.91% | 30.72% | 267.80% | 62.45% | -25.46% |
| Change in Net Operating Assets | -106.20% | -148.06% | -131.74% | -117.87% | -107.04% |
| Cash from Operations | -77.33% | -83.42% | -78.85% | -71.63% | -57.72% |
| Capital Expenditure | -14.91% | -14.98% | 58.12% | 56.42% | 60.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 66.37% | 65.06% | 73.86% | -- | -1,479.86% |
| Cash from Investing | 58.19% | 56.56% | 69.99% | -325.40% | -424.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -80.85% | 13.33% | 13.33% | 13.33% |
| Repurchase of Common Stock | 58.68% | 87.99% | 93.67% | 92.82% | 99.24% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 99.64% | 99.02% | 74.38% | 49.68% | 26.39% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 98.94% | 98.10% | 77.48% | 66.80% | 71.94% |
| Foreign Exchange rate Adjustments | 148.48% | 165.28% | 36.97% | 11.72% | 25.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.10% | -152.04% | -94.06% | -145.62% | -557.39% |